Which statement is true about double-blinded studies?

Which statement is true about double-blinded studies?

• A. The treatment allocation is concealed from both participants and researchers
• B. The treatment is disclosed to participants only
• C. No randomization is used
• D. Neither the participants nor the researchers know the treatment allocation

Answer: (A)

Double-blind trials hinge on concealment of the assignment so that neither the people receiving care nor those evaluating outcomes can deduce which treatment a participant received. This hidden allocation stops expectations, beliefs, or behaviors from swaying results, whether through how care is given, how patients report symptoms, or how outcomes are assessed. Describing the allocation as being concealed from both participants and researchers captures this essential mechanism. If the assignment were disclosed to participants or to those delivering or evaluating care, bias could creep in through placebo effects, differential care, or biased outcome assessment. While in many double-blind designs no one involved in the assessment or treatment knows the assignment, the key point reinforced here is that concealment from both sides preserves objectivity and integrity of the comparison. The other options either imply disclosure to one group, deny randomization, or state the blinding more vaguely, which doesn’t pinpoint how double-blind trials minimize bias.

Double-blind trials hinge on concealment of the assignment so that neither the people receiving care nor those evaluating outcomes can deduce which treatment a participant received. This hidden allocation stops expectations, beliefs, or behaviors from swaying results, whether through how care is given, how patients report symptoms, or how outcomes are assessed.

Describing the allocation as being concealed from both participants and researchers captures this essential mechanism. If the assignment were disclosed to participants or to those delivering or evaluating care, bias could creep in through placebo effects, differential care, or biased outcome assessment. While in many double-blind designs no one involved in the assessment or treatment knows the assignment, the key point reinforced here is that concealment from both sides preserves objectivity and integrity of the comparison. The other options either imply disclosure to one group, deny randomization, or state the blinding more vaguely, which doesn’t pinpoint how double-blind trials minimize bias.